Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoliyuan
- Development stage
- Unknown
- Lead developer
- Beijing Boya Research Institution
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Huoliyuan is a traditional Chinese medicine (TCM) prescription drug available in capsule and tablet formulations, primarily manufactured by China YCT International Group. Developed by the Beijing Boya Research Institution, the formulation contains a blend of herbal extracts including Panax Ginseng leaves, Radix Astragali (Astragalus), Radix Ophiopogonis, Schisandra Chinensis, and Monkshood (Aconitum). It is traditionally used to treat conditions characterized by Qi and Yin deficiency, such as fatigue, heart palpitations, and shortness of breath. It is also utilized as an adjunctive therapy for coronary heart disease, chronic hepatitis, and leukopenia. The therapeutic effect is derived from the synergistic action of its botanical constituents, which are believed to modulate metabolic and cardiovascular pathways.
- Brand names
- Huoliyuan
- Other names
- Huoliyuan CapsuleHuoliyuan Tablet
Beyond the preview
Go deeper on Huoliyuan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huoliyuan.